Can Xolair (Omalizumab) affect food taste?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Xolair (omalizumab) is not typically known to cause taste disturbances as a common side effect. While many medications can affect taste perception, altered taste (dysgeusia) is not listed among the common or even rare side effects of Xolair in clinical studies or post-marketing surveillance 1, 2, 3, 4, 5. Xolair is a monoclonal antibody that works by binding to IgE antibodies in the bloodstream, preventing them from triggering allergic reactions, particularly in conditions like severe asthma and chronic urticaria (hives). This mechanism of action does not directly involve taste receptors or the neurological pathways responsible for taste perception.

Key Points to Consider

  • The most recent and highest quality study on the topic is from 2024, which focused on the use of omalizumab for the treatment of multiple food allergies, but did not mention taste disturbances as a side effect 3.
  • Other studies have also not reported taste disturbances as a common side effect of Xolair 1, 2, 4, 5.
  • If you are experiencing changes in taste while taking Xolair, it's essential to discuss this with your healthcare provider as it may be related to another medication you're taking, an underlying condition, or possibly an uncommon reaction to Xolair that should be documented.
  • Your doctor can help determine the cause and may consider adjusting your treatment if necessary. Some potential considerations for changes in taste include:
  • Other medications that may be contributing to the taste disturbance
  • Underlying conditions that could be affecting taste perception
  • Uncommon reactions to Xolair that have not been widely reported in clinical studies or post-marketing surveillance.

References

Research

Spotlight on omalizumab in allergic asthma.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 2004

Research

Omalizumab for the Treatment of Multiple Food Allergies.

The New England journal of medicine, 2024

Research

Omalizumab facilitates rapid oral desensitization for peanut allergy.

The Journal of allergy and clinical immunology, 2017

Research

[Anti IgE antibodies for the treatment of difficult asthma].

Revue des maladies respiratoires, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.